Author

Kai Miao

Every paper listing this name carries an ORCID.

Identified by ORCID

Kai MiaoiD2 papers · University of Macau

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Bo Li· 1 shared Changhua ZhangiD· 1 shared Chu‐Xia DengiD· 1 shared Dai-Yang XiaiD· 1 shared Dongyang TangiD· 1 shared Fangyuan ShaoiD· 1 shared Hao XiaoiD· 1 shared Hao-Tong Luo· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bo Li

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Host-derived Lactobacillus plantarum alleviates hyperuricemia by improving gut microbial community and hydrolase-mediated degradation of purine nucleosides

Yang Fu, Xiao-Dan Luo, Jin-Ze Li, Qian-Yuan Mo, Xue Wang, Yue Zhao, You-Ming Zhang, Hao-Tong Luo, Dai-Yang Xia, Wei-Qing Ma, Jian-Ying Chen, Li-Hua Wang, Qiu-Yi Deng, Lukuyu Ben, Muhammad Kashif Saleemi, , Wen-Ce Wang

This study shows that host-derived Lactobacillus plantarum strain SQ001 alleviates hyperuricemia by improving gut microbiota and enhancing purine nucleoside degradation.

eLife · Oct 9, 2024Peer-reviewedMicrobiology

A critical role of protein damage response in mediating cancer drug resistance

Fangyuan Shao, Jie Li, Hao Xiao, Ling Li, Bo Li, Y H Chen, Xiangpeng Chu, Maoxin Ran, Dongyang Tang, Yuzhong Peng, Yujian Huang, Lijian Wang, Yanxia Shi, Nan Shao, Kai Miao, , Chu‐Xia Deng

This study identifies protein damage response (PDR) as a key mechanism in cancer drug resistance, showing that targeting PDR components can enhance drug efficacy in resistant cells.

bioRxiv · Jul 17, 2024 · PreprintCancer Biology